Dr Thomas Mackenzie Leavenworth, MD | |
1410 N 4th St, Clinton, IA 52732-2940 | |
(563) 244-3641 | |
Not Available |
Full Name | Dr Thomas Mackenzie Leavenworth |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 1410 N 4th St, Clinton, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346230539 | NPI | - | NPPES |
1346230539 | Other | IA | BLUE SHIELD |
1346230539 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 22498 (Iowa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Mackenzie Leavenworth, MD 900 Stone Mill Rd, Tipton, IA 52772-9238 Ph: () - | Dr Thomas Mackenzie Leavenworth, MD 1410 N 4th St, Clinton, IA 52732-2940 Ph: (563) 244-3641 |
News Archive
When imaging the brain, time is critical as vascular abnormalities can have a profound effect on patients' lives if not diagnosed quickly. To help health care facilities diagnose disease with greater accuracy and speed, Toshiba America Medical Systems, Inc. has introduced Variable True Rate Angiography with Combined Encodings, an exclusive MRA sequence available on all Vantage TitanTM and Vantage Atlas® MR systems.
Treasury Secretary Timothy Geithner sharpened the Obama administration's criticism of Republican fiscal policy in a speech Thursday, pushing back against the GOP on calls for immediate spending cuts and long-term plans for Social Security and Medicare.
Roughly 45 million adult Americans smoke and this is much lesser than the figures a few years back. Even those who still smoke have cut back on the number of cigarettes they smoke, but the rate of decline has begun to slow, U.S. health experts said on Tuesday. Smoking and exposure to secondhand smoke is the leading cause of preventable death and disease in the United States, killing an estimated 443,000 Americans each year.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
› Verified 2 days ago
Christina Marie Shimak Morton, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1410 N 4th St, Mercy Medical Center, Clinton, IA 52732 Phone: 563-244-5555 | |
Mr. Dennis D Boekhoff, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1410 N 4th St, Clinton, IA 52732 Phone: 563-244-5555 |